Antimicrobial management and appropriateness of treatment of urinary tract infection in general practice in Ireland

BMC Family Practice

Volumn 12, Issue , 2011, Pages

  Vellinga, Akke ^a   Cormican, Martin ^a,b   Hanahoe, Belinda ^b   Bennett, Kathleen ^c   Murphy, Andrew W ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY HOSPITAL GALWAY   (Ireland)

^c TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

antimicrobial prescribing; management; UTI

Indexed keywords

EID: 80053459219     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-12-108     Document Type: Article

References (51)

1. Uncomplicated Urinary Tract Infection. Bishop MC, EAU Update Series 2004 2 143 150 10.1016/j.euus.2004.08.003 (Pubitemid 39248450)
2. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD, BMJ 2010 340 2096 10.1136/bmj.c2096 20483949
3. Urinary tract infections in adult general practice patients. Hummers-Pradier E, Kochen MM, Br J Gen Pract 2002 52 752 761 12236281 (Pubitemid 36187600)
4. Predictive value of antimicrobial susceptibility from previous urinary tract infection in the treatment of re-infection. Vellinga A, Cormican M, Hanahoe B, Murphy AW, Br J Gen Pract 2010 60 511 513 10.3399/bjgp10X514765 20594440
5. Managing UTI in primary care: should we be sending midstream urine samples? Hay AD, Br J Gen Pract 2010 60 479 480 10.3399/bjgp10X514701 20594436
6. Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults. Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM, Clin Infect Dis 2005 40 643 654 10.1086/427507 15714408 (Pubitemid 40381336)
7. International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Gupta K, Hooton TM, Naber KG, Wullt Br, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, et al. Clinical Infectious Diseases 2011 52 103 e120 10.1093/cid/ciq257 21292654
8. Antimicrobial agents for treating uncomplicated urinary tract infection in women. Zalmanovici Trestioreanu A, Green H, Paul M, Yaphe J, Leibovici L, Cochrane Database Syst Rev 2010 10 D007182 20927755
9. Antimicrobial resistance in E.coli associated with urinary tract infection in the west of Ireland. Chulain MN, Murray AM, Corbett-Feeney G, Cormican M, Ir J Med Sci 2005 174 6 9 10.1007/BF03168974 16445153 (Pubitemid 43141437)
10. Diagnosis and management of uncomplicated urinary tract infections. Mehnert-Kay SA, Am Fam Physician 2005 72 451 456 16100859
11. Opt-out as an acceptable method of obtaining consent in medical research: a short report. Vellinga A, Cormican M, Hanahoe B, Bennett K, Murphy A, BMC Med Res Meth 2011 11 40 10.1186/1471-2288-11-40
12. ACP Best Practice No 167. Graham JC, Galloway A, Journal of Clinical Pathology 2001 54 911 919 10.1136/jcp.54.12.911 11729209
13. Subcommittee on Antimicrobial Susceptibility Testing. http://www.clsi.org/Content/NavigationMenu/Committees/Microbiology/AST/AST.htm
14. WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Abramson J, Epidemiologic Perspectives & Innovations 2004 1 6 10.1186/1742-5573-1-6 21959574 (Pubitemid 40404933)
15. Urinalysis: a comprehensive review. Simerville JA, Maxted WC, Pahira JJ, Am Fam Physician 2005 71 1153 1162 15791892 (Pubitemid 40395673)
16. Infections caused by Gram-positive bacteria: a review of the global challenge. Woodford N, Livermore DM, J Infect 2009 59 4 16 19766888
17. Plasmid-mediated quinolone resistance: a multifaceted threat. Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A, Clin Microbiol Rev 2009 22 664 689 10.1128/CMR.00016-09 19822894
18. The worldwide emergence of plasmid-mediated quinolone resistance. Robicsek A, Jacoby GA, Hooper DC, Lancet Infect Dis 2006 6 629 640 10.1016/S1473-3099(06)70599-0 17008172 (Pubitemid 44427732)
19. Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapy. Lautenbach E, Metlay JP, Bilker WB, Edelstein PH, Fishman NO, Clin Infect Dis 2005 41 923 929 10.1086/432940 16142655 (Pubitemid 41368212)
20. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome. Ortega M, Marco F, Soriano A, Almela M, Martinez JA, Munoz A, Mensa J, J Antimicrob Chemother 2009 63 568 574 10.1093/jac/dkn514 19126669
21. Broad-Spectrum Antimicrobials and the Treatment of Serious Bacterial Infections: Getting It Right Up Front. Kollef MH, Clin Infect Dis 2008 47 3 S13 10.1086/590061 18713047
22. A qualitative study of factors influencing antimicrobial prescribing by non-consultant hospital doctors. De Souza V, MacFarlane A, Murphy AW, Hanahoe B, Barber A, Cormican M, J Antimicrob Chemother 2006 58 840 843 10.1093/jac/dkl323 16885179 (Pubitemid 44390962)
23. Improving Antibiotic Selection: A Systematic Review and Quantitative Analysis of Quality Improvement Strategies. Steinman MA, Ranji SR, Shojania KG, Gonzales R, Medical Care 2006 44 617 628 10.1097/01.mlr.0000215846.25591.22 16799356 (Pubitemid 44284275)
24. Investigation of Urine. Health Protection Agency, National Standard Method BSOP 2009 41
25. Management of urinary tract infections in female general practice patients. Hummers-Pradier E, Ohse AM, Koch M, Heizmann WR, Kochen MM, Fam Pract 2005 22 71 77 15640290 (Pubitemid 40309608)
26. Clinical management of urinary tract infection in women: a prospective cohort study. Fahey T, Webb E, Montgomery AA, Heyderman RS, Fam Pract 2003 20 1 6 10.1093/fampra/20.1.1 12509362 (Pubitemid 36163776)
27. An observational study of empirical antibiotics for adult women with uncomplicated UTI in general practice. O'Brien K, Hillier S, Simpson S, Hood K, Butler C, J Antimicrob Chemother 2007 59 1200 1203 10.1093/jac/dkm108 17449887 (Pubitemid 47073335)
28. The relationship between primary care antibiotic prescribing and bacterial resistance in adults in the community: a controlled observational study using individual patient data. Hay AD, Thomas M, Montgomery A, Wetherell M, Lovering A, McNulty C, Lewis D, Carron B, Henderson E, MacGowan A, J Antimicrob Chemother 2005 56 146 153 10.1093/jac/dki181 15928011 (Pubitemid 41418349)
29. Monitoring antibiotic resistance in urinary isolates from the community - a spotter practice model. Richards J, Commun Dis Public Health 2002 5 226 229 12434693
30. Can routine laboratory data guide empirical prescribing? Ludlam H, Sule O, Knapton M, Abubakar I, J Clin Pathol 2004 57 672 10.1136/jcp.2003.012971 15166286
31. Management of infection guidance for primary care in Ireland (Draft). http://www.hpsc.ie/hpsc/A-Z/MicrobiologyAntimicrobialResistance/ StrategyforthecontrolofAntimicrobialResistanceinIrelandSARI/ Communityantibioticstewardship/File,3334,en.pdf
32. Predictive value of antimicrobial susceptibility from previous urinary tract infection in the treatment of re-infection. Vellinga A, Cormican M, Hanahoe B, Murphy AW, Br J Gen Pract 2010 60 511 513 10.3399/bjgp10X514765 20594440
33. The adherence of GPs to guidelines for the diagnosis and treatment of lower urinary tract infections in women is poor. Llor C, Rabanaque G, Lopez A, Cots JM, Fam Pract 2010
34. Behandeling van urineweginfecties binnen en buiten pracktijkuren. Bergeijk HV, Berger M, Huisarts Wet 2008 51 430 433 10.1007/BF03086875
35. A multilevel analysis of trimethoprim and ciprofloxacin prescribing and resistance of uropathogenic Escherichia coli in general practice. Vellinga A, Murphy AW, Hanahoe B, Bennett K, Cormican M, J Antimicrob Chemother 2010 65 1514 1520 10.1093/jac/dkq149 20457673
36. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Gupta K, Hooton TM, Stamm WE, Ann Intern Med 2001 135 41 50 11434731 (Pubitemid 32619282)
37. Antimicrobial drug use and resistance in Europe. van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H, Ferech M, Emerg Infect Dis 2008 14 1722 1730 10.3201/eid1411.070467 18976555
38. Antimicrobial resistance in the UK and Ireland. Reynolds R, J Antimicrob Chemother 2009 64 19 i23 10.1093/jac/dkp257 19675014
39. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. Naber K, Schito G, Botto H, Palou J, Mazzei T, Eur Urol 2008 54 1164 1175 10.1016/j.eururo.2008.05.010 18511178
40. Guidelines on uncomplicated urinary tract infections are difficult to follow: perceived barriers and suggested interventions. Lugtenberg M, Burgers JS, Zegers-van Schaick JM, Westert GP, BMC Fam Pract 2010 11 51 10.1186/1471-2296-11-51 20584276
41. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Goossens H, Ferech M, Vander Stichele R, Elseviers M, Lancet 2005 365 579 587 15708101 (Pubitemid 40247914)
42. Outpatient antibiotic use in the four administrations of the UK: cross-sectional and longitudinal analysis. Davey P, Ferech M, Ansari F, Muller A, Goossens H, J Antimicrob Chemother 2008 62 1441 1447 10.1093/jac/dkn386 18786937
43. Impact of Quinolone Restriction on Resistance Patterns of Escherichia coli Isolated from Urine by Culture in a Community Setting. Gottesman BS, Carmeli Y, Shitrit P, Chowers M, Clin Infect Dis 2009 49 869 875 10.1086/605530 19686074
44. Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use. Sundqvist M, Geli P, Andersson DI, Sjolund-Karlsson M, Runehagen A, Cars H, Abelson-Storby K, Cars O, Kahlmeter G, J Antimicrob Chemother 2010 65 350 360 10.1093/jac/dkp387 19900952
45. Reducing antimicrobial resistance in the community by restricting prescribing: can it be done? Enne VI, J Antimicrob Chemother 2010 65 179 182 10.1093/jac/dkp443 20008449
46. Antibacterial prescribing in primary care. Petersen I, Hayward AC, J Antimicrob Chemother 2007 60 43 47 10.1093/jac/dkm156 17656380
47. Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women. Christiaens T, De Meyere M, Verschraegen G, Peersman W, Heytens S, De Maeseneer J, Br J Gen Pract 2002 52 729 734 12236276 (Pubitemid 36187595)
48. Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection? - results of a randomized controlled pilot trial. Bleidorn J, Gagyor I, Kochen MM, Wegscheider K, Hummers-Pradier E, BMC Med 2010 8 30 10.1186/1741-7015-8-30 20504298
49. The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study. Ferry S, Holm S, Stenlund H, Lundholm R, Monsen T, Scand J Infect Dis 2004 36 296 301 10.1080/00365540410019642 15198188 (Pubitemid 38714183)
50. Antibiotic resistance: a guide for effective prescribing in women's health. Roe VA, J Midwifery Womens Health 2008 53 216 226 10.1016/j.jmwh.2008. 01.003 18455096 (Pubitemid 351597912)
51. Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli. Sandegren L, Lindqvist A, Kahlmeter G, Andersson DI, J Antimicrob Chemother 2008 62 495 503 10.1093/jac/dkn222 18544599